RP-4029 is a selective, covalent hPoltheta inhibitor (IC50s: 0.013 nM for hPoltheta, 6.6 nM for mPoltheta). RP-4029 can be used in the research of homologous recombination (HR)-deficient cancers[1].
Molecular Weight:
623.57
Formula:
C29H23F6N3O4S
Target:
DNA/RNA Synthesis
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
